Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 2/20 | 0.47 |
| ▸ | HTR1A | P08908 | 14/20 | 0.43 |
| ▸ | HTR1D | P28221 | 12/20 | 0.43 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.42 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.42 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.42 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9033461 | 0.80 | CA2 (0.51) | CA2HTR1AHTR1DSIGMAR1ADRA2A | |
| SCHEMBL8640922 | 0.78 | CA2 (0.47) | CA2HTR1AHTR1DSIGMAR1ADRA2A | |
| SCHEMBL31575339 | 0.77 | CA2 (0.54) | CA2HTR1AHTR1DSIGMAR1ADRA2A | |
| SCHEMBL1383106 | 0.76 | CA2 (0.59) | CA2HTR1AHTR1DSIGMAR1ADRA2A | |
| SCHEMBL430983 | 0.76 | CA2 (0.59) | CA2HTR1AHTR1DSIGMAR1ADRA2A | |
| SCHEMBL6084492 | 0.76 | CA2 (0.59) | CA2HTR1AHTR1DSIGMAR1ADRA2A | |
| SCHEMBL29698783 | 0.75 | CA2 (0.51) | CA2HTR1AHTR1DSIGMAR1ADRA2A | |
| SCHEMBL10203012 | 0.75 | CA2 (0.51) | CA2HTR1AHTR1DSIGMAR1ADRA2A | |
| SCHEMBL8426656 | 0.75 | CA2 (0.51) | CA2HTR1AHTR1DSIGMAR1ADRA2A | |
| SCHEMBL7209888 | 0.75 | CA2 (0.49) | CA2HTR1AHTR1DSIGMAR1ADRA2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5824682-A | Vasoconstrictive dihydrobenzopyran derivatives | JANSSEN PHARMACEUTICA, N.V. (BE) | 1998-10-20 | — | — | US | disclosed |